A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients

[1] Alvarez RH(2007)The biology of chronic myelogenous leukemia: implications for imatinib therapy Semin Hematol 44 S4-14

[2] Kantarjian H(1987)The BCR/ABL hybrid gene Baillieres Clin Haematol 1 983-999

[3] Cortes JE(2004)Animal models of chronic myelogenous leukemia Hematol Oncol Clin North Am 18 525-543

[4] Groffen J(2008)Translation of the Philadelphia chromosome into therapy for CML Blood 112 4808-4817

[5] Heisterkamp N(2009)Perspectives on the development of imatinib and the future of cancer research Nat Med 15 1149-1152

[6] Ilaria RL(2007)Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia Blood 110 2242-2249

[7] Druker BJ(2008)P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia J Hematol Oncol 1 15-192

[8] Druker BJ(2008)Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib Haematologica 93 186-5278

[9] O'Hare T(2009)Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation Blood 114 5271-5435

[10] Eide CA(2009)Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter? Blood 114 5426-491

[1] Alvarez RH(2007)The biology of chronic myelogenous leukemia: implications for imatinib therapy Semin Hematol 44 S4-14

[2] Kantarjian H(1987)The BCR/ABL hybrid gene Baillieres Clin Haematol 1 983-999

[3] Cortes JE(2004)Animal models of chronic myelogenous leukemia Hematol Oncol Clin North Am 18 525-543

[4] Groffen J(2008)Translation of the Philadelphia chromosome into therapy for CML Blood 112 4808-4817

[5] Heisterkamp N(2009)Perspectives on the development of imatinib and the future of cancer research Nat Med 15 1149-1152

[6] Ilaria RL(2007)Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia Blood 110 2242-2249

[7] Druker BJ(2008)P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia J Hematol Oncol 1 15-192

[8] Druker BJ(2008)Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib Haematologica 93 186-5278

[9] O'Hare T(2009)Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation Blood 114 5271-5435

[10] Eide CA(2009)Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter? Blood 114 5426-491